Lji Wealth Management, LLC Aurinia Pharmaceuticals Inc. Transaction History

Lji Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$7.13 - $9.49 $85,560 - $113,880	-12,000 Reduced 31.55%	26,030 $234 Million
Q3 2023 Feb 02, 2024	SELL	$7.77 - $12.27 $11,655 - $18,405	-1,500 Reduced 3.79%	38,030 $295 Million
Q2 2023 Feb 02, 2024	SELL	$8.96 - $11.69 $17,920 - $23,380	-2,000 Reduced 4.82%	39,530 $383 Million
Q1 2023 Feb 02, 2024	SELL	$5.94 - $11.27 $43,956 - $83,398	-7,400 Reduced 15.12%	41,530 $455 Million
Q4 2022 Jan 02, 2024	BUY	$4.11 - $8.14 $201,102 - $398,290	48,930 New	48,930 $211 Million

209

58.2M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.16B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Lji Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Lji Wealth Management, LLC with notifications on news.